• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Ultrasensitive electrochemical immunoassay for avian influenza subtype h5 using nanocomposite

tetano

Editor, Senior Moderator
PLoS One. 2014 Apr 14;9(4):e94685. doi: 10.1371/journal.pone.0094685. eCollection 2014.
Ultrasensitive electrochemical immunoassay for avian influenza subtype h5 using nanocomposite.
Xie Z, Huang J, Luo S, Xie Z, Xie L, Liu J, Pang Y, Deng X, Fan Q.
Author information
Abstract

We report a novel electrochemical immunosensor that can sensitively detect avian influenza virus H5 subtype (AIV H5) captured by graphene oxide-H5-polychonal antibodies-bovine serum albumin (GO-PAb-BSA) nanocomposite. The graphene oxide (GO) carried H5-polychonal antibody (PAb) were used as signal amplification materials. Upon signal amplification, the immunosensor showed a 256-fold increase in detection sensitivity compared to the immunosensor without GO-PAb-BSA. We designed a PAb labeling GO strategy and signal amplification procedure that allow ultrasensitive and selective detection of AIV H5. The established method responded to 2-15 HA unit/50 ?L H5, with a linear calibration range from 2-15 to 2-8 HA unit/50 ?L. In summary, we demonstrated that the immunosenser has a high specificity and sensitivity for AIV H5, and the established assay could be potentially applied in the rapid detection of other pathogenic microorganisms.

PMID:
24733043
[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/24733043
 
Back
Top Bottom